Cargando…

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer

BACKGROUND: Increasing evidence supporting the role of immune checkpoint blockade in cancer management has been bolstered by recent reports demonstrating significant and durable clinical responses across multiple tumour types, including metastatic urothelial carcinoma (mUC). The majority of these re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bidnur, S., Savdie, R., Black, P.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927995/ https://www.ncbi.nlm.nih.gov/pubmed/27376121 http://dx.doi.org/10.3233/BLC-150026

Ejemplares similares

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Immune checkpoint blockade therapy for bladder cancer treatment
por: Kim, Jayoung
Publicado: (2016)

Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer—A Review
por: van Hattum, Jons W., et al.
Publicado: (2021)

The role of immune checkpoint inhibition in the treatment of ovarian cancer
por: Gaillard, Stéphanie L., et al.
Publicado: (2016)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
por: Kleinendorst, Simone C., et al.
Publicado: (2022)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023)

Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer
por: Saad, Farouk Tijjani, et al.
Publicado: (2017)

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
por: Rhea, Logan P, et al.
Publicado: (2021)

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
por: Roviello, Giandomenico, et al.
Publicado: (2021)

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
por: Varricchi, Gilda, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors as a Treatment Option for Bladder Cancer: Current Evidence
por: Okobi, Tobechukwu J, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
por: Barone, Biagio, et al.
Publicado: (2022)

Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?
por: Goff, Peter H., et al.
Publicado: (2021)

Immune Checkpoint Inhibition and the Prevalence of Autoimmune Disorders Among Patients With Lung and Renal Cancer
por: El-Refai, Sherif M, et al.
Publicado: (2017)

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
por: Ma, Guang-Long, et al.
Publicado: (2023)

Immune Checkpoint Inhibition in Hodgkin Lymphoma
por: Moy, Ryan H., et al.
Publicado: (2018)

Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
por: Li, Yinuo, et al.
Publicado: (2023)

The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
por: Tinhofer, Ingeborg, et al.
Publicado: (2016)

Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging Evidence
por: Paydary, Koosha, et al.
Publicado: (2021)

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
por: Zhu, Shaoming, et al.
Publicado: (2021)

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
por: Högner, Anica, et al.
Publicado: (2021)

HDAC Inhibition to Prime Immune Checkpoint Inhibitors
por: Borcoman, Edith, et al.
Publicado: (2021)

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer
por: Wills, Beatriz, et al.
Publicado: (2018)

Immune Checkpoints as a Target for Colorectal Cancer Treatment
por: Passardi, Alessandro, et al.
Publicado: (2017)

Immune checkpoint inhibitors in the treatment of virus-associated cancers
por: Gao, Peipei, et al.
Publicado: (2019)

Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment
por: Pirš, Boštjan, et al.
Publicado: (2022)

Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment
por: Alturki, Norah A.
Publicado: (2023)

TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
por: Benoot, Thomas, et al.
Publicado: (2021)

Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
por: Leone, Gian Marco, et al.
Publicado: (2023)

Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
por: Sundar, Raghav, et al.
Publicado: (2020)

MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
por: Zhou, Huiling, et al.
Publicado: (2023)

Targeted Molecular Therapeutics for Bladder Cancer—A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
por: Bednova, Olga, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Prostate Cancer
por: Venkatachalam, Shobi, et al.
Publicado: (2021)

Prospects for combining immune checkpoint blockade with PARP inhibition
por: Li, Anping, et al.
Publicado: (2019)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

The paradox of immune checkpoint inhibition re-activating tuberculosis
por: Ahmed, Mohamed, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
por: Onoi, Keisuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ki2s68rab238t9jn8scam80k01